Literature DB >> 31862751

8. Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes-2020.

.   

Abstract

The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc20-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc20-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
© 2019 by the American Diabetes Association.

Entities:  

Mesh:

Year:  2020        PMID: 31862751     DOI: 10.2337/dc20-S008

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  56 in total

Review 1.  Regression from prediabetes to normal glucose regulation: State of the science.

Authors:  Anthony Sallar; Samuel Dagogo-Jack
Journal:  Exp Biol Med (Maywood)       Date:  2020-03-25

2.  GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in obese mice.

Authors:  Ricardo J Samms; Michael E Christe; Kyla Al Collins; Valentina Pirro; Brian A Droz; Adrienne K Holland; Jessica L Friedrich; Samantha Wojnicki; Debra L Konkol; Richard Cosgrove; Ellen Ps Conceição Furber; Xiaoping Ruan; Libbey S O'Farrell; Annie M Long; Mridula Dogra; Jill A Willency; Yanzhu Lin; Liyun Ding; Christine C Cheng; Over Cabrera; Daniel A Briere; Jorge Alsina-Fernandez; Ruth E Gimeno; Julie S Moyers; Tamer Coskun; Matthew P Coghlan; Kyle W Sloop; William C Roell
Journal:  J Clin Invest       Date:  2021-06-15       Impact factor: 14.808

3.  Weight Change, Lifestyle, and Mortality in Patients With Type 2 Diabetes.

Authors:  Jinbo Hu; Yang Hu; Ellen Hertzmark; Chen Yuan; Gang Liu; Meir J Stampfer; Eric B Rimm; Frank B Hu; Molin Wang; Qi Sun
Journal:  J Clin Endocrinol Metab       Date:  2022-02-17       Impact factor: 5.958

4.  Trends in Obesity and Medical Expenditure among Women with Diabetes, 2008-2016: Differences by Race/Ethnicity.

Authors:  Joni S Williams; Kaiwei Lu; Olaitan Akinboboye; Oluwatoyin Olukotun; Zhipeng Zhou; Sneha Nagavally; Leonard E Egede
Journal:  Ethn Dis       Date:  2020-09-24       Impact factor: 1.847

5.  Obesity Pharmacotherapy is Effective in the Veterans Affairs Patient Population: A Local and Virtual Cohort Study.

Authors:  Jay Pendse; Franco Vallejo-García; Andrew Parziale; Mae Callanan; Craig Tenner; José O Alemán
Journal:  Obesity (Silver Spring)       Date:  2021-02       Impact factor: 5.002

6.  Effect of a Smartphone App on Weight Change and Metabolic Outcomes in Asian Adults With Type 2 Diabetes: A Randomized Clinical Trial.

Authors:  Su Lin Lim; Kai Wen Ong; Jolyn Johal; Chad Yixian Han; Qai Ven Yap; Yiong Huak Chan; Yu Chung Chooi; Zhi Peng Zhang; Cheryl Christine Chandra; Anandan Gerard Thiagarajah; Chin Meng Khoo
Journal:  JAMA Netw Open       Date:  2021-06-01

7.  Systematic review and meta-analysis for prevention of cardiovascular complications using GLP-1 receptor agonists and SGLT-2 inhibitors in obese diabetic patients.

Authors:  Kazushi Uneda; Yuki Kawai; Takayuki Yamada; Sho Kinguchi; Kengo Azushima; Tomohiko Kanaoka; Yoshiyuki Toya; Hiromichi Wakui; Kouichi Tamura
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

8.  Epigallocatechin gallate decreases plasma triglyceride, blood pressure, and serum kisspeptin in obese human subjects.

Authors:  Saimai Chatree; Chantacha Sitticharoon; Pailin Maikaew; Kitchaya Pongwattanapakin; Issarawan Keadkraichaiwat; Malika Churintaraphan; Chanakarn Sripong; Rungnapa Sririwichitchai; Sompol Tapechum
Journal:  Exp Biol Med (Maywood)       Date:  2020-10-12

Review 9.  Diabetic Kidney Disease, Cardiovascular Disease and Non-Alcoholic Fatty Liver Disease: A New Triumvirate?

Authors:  Carolina M Perdomo; Nuria Garcia-Fernandez; Javier Escalada
Journal:  J Clin Med       Date:  2021-05-10       Impact factor: 4.241

10.  The Risks of Polycystic Ovary Syndrome and Diabetes Vary by Ethnic Subgroup Among Young Asian Women.

Authors:  Lynn Guo; Nancy P Gordon; Malini Chandra; Olumayowa Dayo; Joan C Lo
Journal:  Diabetes Care       Date:  2021-04-26       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.